Asieris showcases Phase III win in treating precancerous cervical lesions

Asieris presented positive Phase III results at the 2024 Society of Gynecologic Oncology (SGO) Annual Meeting in San Diego, US.

Mar 20, 2024 - 00:00

Asieris showcases Phase III win in treating precancerous cervical lesions

Asieris presented positive Phase III results at the 2024 Society of Gynecologic Oncology (SGO) Annual Meeting in San Diego, US.

Read the original article

Tags:

Previous Article

Eli Lilly’s partnership with Amazon to boost presence in diabetes and obesity ma...

AstraZeneca to acquire radioconjugate biotech Fusion in $2.4bn deal

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

LCRF, Daiichi Sankyo and AstraZeneca enter research collaboration

LCRF, Daiichi Sankyo and AstraZeneca enter research col...

Mar 19, 2023

FDA warns of reduced efficacy for oral birth control pill Tydemy

FDA warns of reduced efficacy for oral birth control pi...

Aug 2, 2023

GLB-001 by GluBio Therapeutics for Relapsed Acute Myelo...

Dec 20, 2023